Literature DB >> 21494358

Benefits of surgical treatment for unruptured intracranial aneurysms in elderly patients.

E-Wook Jang1, Jin-Young Jung, Chang-Ki Hong, Jin-Yang Joo.   

Abstract

OBJECTIVE: Due to longer life spans, patients newly diagnosed with unruptured intracranial aneurysms (UIAs) are increasing in number. This study aimed to evaluate how management of UIAs in patients age 65 years and older affects the clinical outcomes and post-procedural morbidity rates in these patients.
METHODS: We retrospectively reviewed 109 patients harboring 136 aneurysms across 12 years, between 1997 and 2009, at our institute. We obtained the following data from all patients : age, sex, location and size of the aneurysm(s), presence of symptoms, risk factors for stroke, treatment modality, and postoperative 1-year morbidity and mortality. We classified these patients into three groups : Group A (surgical clipping), Group B (coil embolization), and Group C (observation only).
RESULTS: Among the 109 patients, 56 (51.4%) underwent clipping treatment, 25 (23%) patients were treated with coiling, and 28 observation only. The overall morbidity and mortality rates were 2.46% and 0%, respectively. The morbidity rate was 1.78% for clipping and 4% for coiling. Factors such as hypertension, diabetes mellitus, hypercholesterolemia, smoking, and family history of stroke were correlated with unfavorable outcomes. Two in the observation group refused follow-up and died of intracranial ruptured aneurysms. The observation group had a 7% mortality rate.
CONCLUSION: Our results show acceptable favorable outcome of treatment-related morbidity comparing with the natural history of unruptured cerebral aneurysm. Surgical clipping did not lead to inferior outcomes in our study, although coil embolization is generally more popular for treating elderly patients. In the treatment of patients more than 65 years old, age is not the limiting factor.

Entities:  

Keywords:  Clipping; Coil embolization; Elderly patients; Risk factors; Treatment-related morbidity; Unruptured intracranial aneurysms

Year:  2011        PMID: 21494358      PMCID: PMC3070890          DOI: 10.3340/jkns.2011.49.1.20

Source DB:  PubMed          Journal:  J Korean Neurosurg Soc        ISSN: 1225-8245


  27 in total

1.  Is the aspect ratio a reliable index for predicting the rupture of a saccular aneurysm?

Authors:  H Ujiie; Y Tamano; K Sasaki; T Hori
Journal:  Neurosurgery       Date:  2001-03       Impact factor: 4.654

2.  Recommendations for the endovascular treatment of intracranial aneurysms: a statement for healthcare professionals from the Committee on Cerebrovascular Imaging of the American Heart Association Council on Cardiovascular Radiology.

Authors:  S Claiborne Johnston; Randall T Higashida; Daniel L Barrow; Louis R Caplan; Jacques E Dion; George Hademenos; L Nelson Hopkins; Andrew Molyneux; Robert H Rosenwasser; Fernando Vinuela; Charles B Wilson
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

3.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

4.  Prevalence and risk of rupture of intracranial aneurysms: a systematic review.

Authors:  G J Rinkel; M Djibuti; A Algra; J van Gijn
Journal:  Stroke       Date:  1998-01       Impact factor: 7.914

5.  Morbidity and mortality from surgical treatment of unruptured cerebral aneurysms at Research Institute for Brain and Blood Vessels-Akita.

Authors:  Junta Moroi; Hiromu Hadeishi; Akifumi Suzuki; Nobuyuki Yasui
Journal:  Neurosurgery       Date:  2005-02       Impact factor: 4.654

6.  Effects of size and shape (aspect ratio) on the hemodynamics of saccular aneurysms: a possible index for surgical treatment of intracranial aneurysms.

Authors:  H Ujiie; H Tachibana; O Hiramatsu; A L Hazel; T Matsumoto; Y Ogasawara; H Nakajima; T Hori; K Takakura; F Kajiya
Journal:  Neurosurgery       Date:  1999-07       Impact factor: 4.654

7.  Natural history of unruptured intracranial aneurysms: probability of and risk factors for aneurysm rupture.

Authors:  S Juvela; M Porras; K Poussa
Journal:  J Neurosurg       Date:  2000-09       Impact factor: 5.115

8.  The unchanging pattern of subarachnoid hemorrhage in a community.

Authors:  L H Phillips; J P Whisnant; W M O'Fallon; T M Sundt
Journal:  Neurology       Date:  1980-10       Impact factor: 9.910

9.  Stratification of outcome for surgically treated unruptured intracranial aneurysms.

Authors:  Christopher S Ogilvy; Bob S Carter
Journal:  Neurosurgery       Date:  2003-01       Impact factor: 4.654

10.  Epidemiology of the size distribution of intracranial bifurcation aneurysms: smaller size of distal aneurysms and increasing size of unruptured aneurysms with age.

Authors:  Bob S Carter; Sunil Sheth; Eric Chang; Manish Sethl; Christopher S Ogilvy
Journal:  Neurosurgery       Date:  2006-02       Impact factor: 4.654

View more
  5 in total

1.  Treatment outcome after coiling or clipping for elderly patients with unruptured intracranial aneurysms.

Authors:  Woo Cheul Cho; Yong Sam Shin; Bum-Soo Kim; Jai Ho Choi
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2020-06-30

2.  Long-Term Rupture Risk in Patients with Unruptured Intracranial Aneurysms Treated with Endovascular Therapy: A Systematic Review and Meta-Analysis.

Authors:  A Rizvi; S M Seyedsaadat; M Alzuabi; M H Murad; R Kadirvel; W Brinjikji; D F Kallmes
Journal:  AJNR Am J Neuroradiol       Date:  2020-05-28       Impact factor: 3.825

3.  The natural history and treatment options for unruptured intracranial aneurysms.

Authors:  Joshua E Loewenstein; Shaneze C Gayle; E Jesus Duffis; Charles J Prestigiacomo; Chirag D Gandhi
Journal:  Int J Vasc Med       Date:  2012-02-28

4.  Clinical outcomes of treatment for intracranial aneurysm in elderly patients.

Authors:  Jun Hee Park; Young Im Kim; Yong Cheol Lim
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-09-30

Review 5.  Unruptured Cerebral Aneurysms in Elderly Patients.

Authors:  Tomohito Hishikawa; Isao Date
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-04-19       Impact factor: 1.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.